Press Releases

April 10, 2017

Adapt Pharma announced today that it will donate 20,000 cartons (40,000 doses) of NARCAN® (naloxone hydrochloride) Nasal Spray 4mg to colleges and universities throughout the United States....

March 16, 2017

Adapt Pharma (www.AdaptPharma.com) today presented results of a survey conducted with Police and Community Organizations describing real-world experiences and outcomes with the FDA-approved 4mg...

February 28, 2017

NARCAN® Nasal Spray is the only FDA-approved naloxone nasal spray indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous syste...

February 21, 2017

Adapt Pharma Limited (Adapt Pharma) today announced that a marketing application for Naloxone Hydrochloride (HCl) Nasal Spray for the treatment of opioid overdose has been filed in Europe....

January 25, 2017

Today, the U.S. Food and Drug Administration (FDA) approved NARCAN® Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and...

December 1, 2016

Ohio Attorney General Mike DeWine announced an agreement on Friday, 11/25/16 with Adapt Pharma to provide NARCAN® (naloxone HCl) Nasal Spray 4mg at a discounted rate to state police, first responders,...

November 22, 2016

FDA Suggests that Before Taking Opioids Consumers Ask Their Physician About a Naloxone Prescription ...

November 4, 2016

Reported shortage of non-FDA approved improvised nasal naloxone kits....

October 6, 2016

FDA Joint Meeting Endorses Commitment to Higher Doses and Broader Access for Naloxone to Help in Fight Against Opioid Overdose ...

October 5, 2016

Adapt Pharma Announces NARCAN® coverage with California’s Medi-Cal Program. Agreement Results in Restriction-Free, $0 Copay Access to NARCAN® Nasal Spray for Millions of Californians...

October 3, 2016

Existing Interim Order Allows Continuing Access in Canada to the US FDA-approved Narcan® Nasal Spray Pending Launch of the Health Canada Approved Version...

October 3, 2016

En attendant le lancement de la version approuvée par Santé Canada, l’Arrêté d’urgence existant permet aux Canadiens de continuer de se procurer le vaporisateur nasal Narcan® approuvé par la FDA des É...

September 20, 2016

Newly Published Study Finds NARCAN® Nasal Spray’s Concentrated Formulation Rapidly Delivers an Effective Naloxone Dose and is Readily Usable by the General Public...

July 12, 2016

Adapt Pharma to Launch Program to Raise Awareness, Expand Access and Facilitate Product Experience of NARCAN® (Naloxone HCl) Nasal Spray - a new Treatment for Opioid Overdose...

July 6, 2016

Earlier today, Health Canada announced it will establish temporary access to the only U.S. Food and Drug Administration (FDA) approved, intranasal version of naloxone, NARCAN® Nasal Spray, the medicat...

May 2, 2016

Adapt Pharma submits NDS to Health Canada for Naloxone Nasal Spray...

April 28, 2016

Today, high schools across the country can join their communities in the battle against the opioid epidemic...

April 14, 2016

Introducing the NARCAN® Now App, a smartphone application providing opioid overdose recognition education and treatment instructions...

April 11, 2016

Adapt Pharma Names Mike Kelly President of U.S. Operations. Contributing Over 25 Years of Pharmaceutical Expertise to Adapt Executive Team...

February 25, 2016

Adapt Pharma, Limited (www.adaptpharma.com) today announced the United States (U.S.) commercial availability of NARCAN® (Naloxone Hydrochloride) Nasal Spray...

January 25, 2016

Adapt Pharma to offer all U.S. high schools a free NARCAN® Nasal Spray...

January 14, 2016

Adapt Pharma facilitates NARCAN® (naloxone hydrochloride) Nasal Spray access to state and local public entities...

November 19, 2015

NARCAN® (naloxone hydrochloride) Nasal Spray approved by U.S. food and drug administration...

September 24, 2015

FDA accepts for review Adapt Pharma’s NARCAN® (naloxone hydrochloride) Nasal Spray NDA...

July 27, 2015

Adapt Pharma submits NDA to FDA for NARCAN® (Naloxone) Nasal Spray...

July 2, 2015

Adapt Pharma acquires NARCAN NDA and obtains license to the NARCAN® trademark...

June 3, 2015

Adapt Pharma Commences Rolling NDA Submission to the FDA for Intranasal Naloxone...

April 22, 2015

Adapt Pharma Announces Successful Completion of Intranasal Naloxone Study...

February 17, 2015

Adapt Pharma Announces Fast Track Designation From FDA for Naloxone Nasal Spray...

January 5, 2015

Adapt Pharma and Profector Life Sciences Enter a Development and Investment Collaboration...

December 16, 2014

Adapt Pharma Announces License Agreement for Naloxone Nasal Spray With Lightlake Therapeutics Inc....

May 2, 2014

Adapt Pharma Completes $95 Million Equity Financing U.S. Focused Specialty Pharmaceutical Company...